Biotechnology
Taiwan's biopharma sector steps into spotlight with rush of IPOs
Taipei fosters growth to support economy, security alongside semiconductors
A lab where Taiwan Bio-Manufacturing Corp. conducts process analysis and development for biopharmaceutical products. (TBMC)
TOKYO -- Taiwan's biopharmaceutical sector is growing, with seven companies going public in the first half of 2026, helped by the government's push to nurture the next strategic industries after semiconductors.